Who is at risk
- Age — risk climbs after 45, though cases in younger adults are rising.
- Family history of colorectal cancer or advanced polyps, especially in a parent, sibling or child.
- Inherited syndromes — Lynch syndrome and familial adenomatous polyposis carry high lifetime risk and change when screening should start.
- Inflammatory bowel disease — long-standing ulcerative colitis or Crohn's colitis.
- Lifestyle — smoking, heavy alcohol, obesity, physical inactivity, and diets heavy in processed and red meat.
- Type 2 diabetes, and a personal history of prior polyps or colorectal cancer.
Finding it early
Screening works here better than almost anywhere in oncology, because it does not just find cancer early — it removes the polyps that would have become cancer. That is prevention, not just detection.
The U.S. Preventive Services Task Force recommends screening for everyone at average risk from age 45 to 75 (USPSTF, 2021), and individualized decisions from 76 to 85. Start earlier if you have a family history, inflammatory bowel disease, or a known genetic syndrome such as Lynch.
Your options: colonoscopy every 10 years (finds and removes polyps in the same visit); stool-based tests (FIT yearly, or stool DNA every 1–3 years) which are easy and done at home but require a colonoscopy if positive; or CT colonography every 5 years. The best test is the one you will actually do.
Symptoms that should not wait for a screening date — blood in the stool or on the paper, a lasting change in bowel habit, narrow stools, cramping that does not settle, unexplained weight loss, or unexplained iron-deficiency anemia. Rectal bleeding is often hemorrhoids; it is also the most commonly ignored early sign. Get it looked at.
Colorectal cancer is rising in adults under 50. If you are 35 and bleeding, you still deserve a proper evaluation.
How it’s diagnosed
Diagnosis is usually made at colonoscopy: the polyp or tumor is seen and biopsied in the same visit. You are sedated and generally remember little of it; the preparation the day before is the part people mind.
Once cancer is confirmed, staging usually involves CT of the chest, abdomen and pelvis, a blood test called CEA that can be used as a baseline for later monitoring, and — for rectal cancer specifically — a pelvic MRI, which is the study that shows how close the tumor is to the outer edge of the rectum.
Tumor testing matters: MMR/MSI status is checked on essentially all colorectal cancers, because a mismatch-repair-deficient tumor may respond dramatically to immunotherapy and can also point to Lynch syndrome, which has implications for your relatives. RAS and BRAF testing guide drug choice in advanced disease.
Staging explained simply
Stage combines T (how deeply it has grown into the bowel wall), N (lymph nodes) and M (distant spread). For colon cancer, depth through the wall and node status drive almost every decision.
| Stage | What it means in plain words |
|---|---|
| Stage 0 | Abnormal cells confined to the inner lining. Removing the polyp may be all that is needed. |
| Stage I | Grown into the bowel wall but not through it, with no lymph nodes involved. |
| Stage II | Grown through the wall, still without lymph node involvement. |
| Stage III | Spread to nearby lymph nodes. Still treated with cure as the goal. |
| Stage IV | Spread to distant organs, most often the liver or lungs. Some people with limited spread are still treated for cure. |
Grading and biology
Stage is how far it has travelled; grade is how abnormal the cells look. Low-grade (well-differentiated) cells resemble normal tissue and generally behave more predictably; high-grade cells look disordered and tend to move faster.
Two other features are reported and worth asking about: whether cancer is seen in small blood or lymph vessels (lymphovascular invasion), and how many lymph nodes were examined — a thorough node count makes the stage more reliable. MMR/MSI status, described above, often influences treatment more than grade does.
How it’s treated
Surgery is the backbone of colon cancer treatment. The segment containing the tumor is removed along with its lymph nodes, and the bowel is usually rejoined. Most people do not need a permanent bag.
Chemotherapy is added after surgery for stage III, and for some stage II tumors with worrying features, to reduce the chance of return. For stage IV it is the main treatment, sometimes alongside surgery to remove limited liver or lung spread with cure still the goal.
Immunotherapy can work remarkably well in the subset of tumors that are mismatch-repair deficient (MSI-high).
Radiation is used far less in colon cancer than in rectal cancer — the colon moves, which makes precise targeting harder, and surgery plus chemotherapy handles most situations. It has a role in selected cases where a tumor is stuck to a fixed structure, and for treating painful or troublesome spread. We would rather tell you plainly that radiation is not the main tool here than overstate our own specialty.
What the guidelines say
In broad strokes: remove it surgically with an adequate lymph node harvest; add chemotherapy when nodes are positive or features are high-risk; test every tumor for mismatch repair status; and for advanced disease, choose drug therapy by molecular results. Surveillance colonoscopy follows on a defined schedule.
Your team will follow national guidelines such as those from the National Comprehensive Cancer Network (NCCN). The description above is a plain-language overview of the general approach, not the guideline itself — your own plan may reasonably differ. NCCN publishes free NCCN Guidelines for Patients® written for exactly this purpose.
Outcomes and odds of cure
Source: NCI SEER Cancer Stat Facts: Colorectal Cancer, SEER 22 (excluding IL/MA), 2014–2020. SEER reports colon and rectal cancers together, so these figures cover both.
| When it is found | Share of cases | 5-year relative survival |
|---|---|---|
| Localized — confined to the bowel wall | 35% | 91.1% |
| Regional — spread to nearby lymph nodes | 36% | 73.7% |
| Distant — spread to other organs | 23% | 15.7% |
| Unstaged | 6% | 48.8% |
These are population statistics from the National Cancer Institute's SEER program. They describe large groups of people, not any one person, and they lag current treatment by several years. They cannot predict what will happen to you.
The pattern here is stark and hopeful at once: caught early this is usually curable, and screening is what determines which column you land in.
Side effects and how we watch for them
After surgery: temporary changes in bowel habit are normal and usually settle over months. Chemotherapy side effects depend on the regimen; oxaliplatin can cause cold-triggered tingling in the hands and feet that needs to be reported early, because dose can be adjusted before it becomes lasting.
How it is assessed: side effects are graded on a standard scale at each visit so changes are tracked over time rather than recalled. Report numbness, persistent diarrhea, fever, or inability to keep fluids down promptly.
Follow-up, remission and survivorship
Remission means no detectable cancer. Surveillance continues because recurrence, if it happens, is most likely in the first few years and is most treatable when caught small.
Typical follow-up after curative treatment: clinical visits and CEA blood tests every few months for the first two to three years, CT scans periodically, and a colonoscopy at one year, then at widening intervals depending on what is found.
If your tumor was mismatch-repair deficient, ask about genetic counselling — it may matter a great deal to your siblings and children.
Questions people actually ask
Will I need a colostomy bag?
For most colon cancers, no. The affected segment is removed and the bowel rejoined in the same operation. Permanent stomas are much more a rectal cancer discussion, and even there they are not automatic.
Can I just do the stool test instead of a colonoscopy?
Yes — a yearly FIT is a legitimate screening strategy and far better than not screening. The trade-off is that it detects rather than prevents, and a positive result means you need a colonoscopy anyway.
I'm under 45 with bleeding. Am I being dramatic?
No. Colorectal cancer is rising in younger adults and is too often dismissed as hemorrhoids. Ask for an evaluation, and ask again if symptoms persist.
Does having a polyp removed mean I had cancer?
Usually not. Most polyps are benign — but some types would have become cancer over years, which is exactly why removing them is so effective.
Why is radiation used for rectal but not colon cancer?
The rectum sits fixed in the pelvis, so it can be targeted precisely. The colon moves with digestion and sits near sensitive small bowel, which makes routine radiation impractical and largely unnecessary.
Informational only, not medical advice — confirm with your care team.
Go deeper on colorectal cancer
Read the full plain-language guide, or ask us whether radiation has any role in your situation.